Lindsay Osleber, MD
Obstetrics & Gynecology · Little Rock, ARNPI 1801020177
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 186 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations.
Across 186 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$452
- AbbVie$435
- Bayer$379
- Astellas Pharma US Inc$296
- Pfizer$272
- Organon$200
- plus $1K from 17 others
Across 5 payments — averaging $565.00 each. An ownership or investment interest held by the physician or an immediate family member.
- Sitesaver Inc.$3K
What the payments were for
- Food & beverage$3,24997%
- Education$853%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 22 | $452 |
| AbbVie | 27 | $435 |
| Bayer | 20 | $379 |
| Astellas Pharma US Inc | 10 | $296 |
| Pfizer | 19 | $272 |
| Organon | 10 | $200 |
| Myovant Sciences Inc. | 12 | $194 |
| Minerva Surgical, Inc | 10 | $157 |
| Hologic Sales And Service, LLC | 9 | $147 |
| Mayne Pharma Commercial LLC | 9 | $123 |
| Merck | 7 | $119 |
| Shield Therapeutics Inc | 6 | $96 |
| Biogen | 4 | $95 |
| Exeltis, USA Inc. | 5 | $88 |
| Avion Pharmaceuticals | 4 | $54 |
| Evofem Biosciences, Inc. | 3 | $52 |
| Aspira Women's Health Inc | 1 | $48 |
| Coopersurgical, Inc. | 2 | $35 |
| Therapeuticsmd, Inc. | 2 | $32 |
| Millicent US Inc | 1 | $20 |
| Smith+Nephew | 1 | $18 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
| Duchesnay USA Incorporated | 1 | $12 |
How this compares
$3,334 in reported general payments places this provider in the 70th percentile of 272 obstetrics & gynecology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 46 | $2,047 |
| Estradiol (Once Weekly)Estradiol | 16 | $580 |
| ValacyclovirValacyclovir Hcl | 32 | $323 |
| ProgesteroneProgesterone, Micronized | 11 | $266 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Little Rock
- Michael CopeLittle Rock$147K
- David ShenkerLittle Rock$28K
- Julia GoodwinLittle Rock$16K
- Ananth RanganathanLittle Rock$11K
- Mary RacherLittle Rock$11K
- Nirvana ManningLittle Rock$10K
- Sharai AmayaLittle Rock$9K
- Emily WilliamsLittle Rock$9K
- Shelly GibbsLittle Rock$8K
- Stacy Ulmer-PinterLittle Rock$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.